Extra Strength Tylenol PM



Indications and Reactions:

Role Indications Reactions
Primary
Insomnia 23.2%
Product Used For Unknown Indication 19.9%
Drug Use For Unknown Indication 9.5%
Pain 8.9%
Sleep Disorder Therapy 7.6%
Hypertension 6.1%
Depression 3.4%
Diabetes Mellitus 3.1%
Cardiac Disorder 2.8%
Arthritis 2.1%
Headache 2.1%
Blood Cholesterol Increased 1.8%
Anxiety 1.5%
Convulsion 1.5%
Bipolar Disorder 1.2%
Hypersensitivity 1.2%
Ill-defined Disorder 1.2%
Arthralgia 0.9%
Blood Cholesterol Abnormal 0.9%
Blood Pressure 0.9%
Product Quality Issue 23.4%
Vomiting 15.6%
Intentional Overdose 7.8%
Dependence 6.3%
Intentional Drug Misuse 5.5%
Suicide Attempt 4.7%
Drug Dependence 3.9%
Hypersensitivity 3.9%
Blood Pressure Increased 3.1%
Overdose 3.1%
Agitation 2.3%
Convulsion 2.3%
Hallucination 2.3%
Insomnia 2.3%
Pruritus 2.3%
Renal Failure 2.3%
Somnolence 2.3%
Transmission Of An Infectious Agent Via A Medicinal Product 2.3%
Weight Decreased 2.3%
Dizziness 1.6%
Secondary
Pain 33.2%
Arthritis 18.4%
Back Injury 16.7%
Insomnia 5.7%
Product Used For Unknown Indication 4.0%
Sleep Disorder Therapy 3.7%
Inflammation 3.3%
Drug Use For Unknown Indication 2.4%
Smoking Cessation Therapy 1.7%
Analgesic Therapy 1.6%
Headache 1.4%
Arthralgia 1.3%
Cardiac Disorder 1.1%
Migraine 1.0%
Pharyngitis 1.0%
Pyrexia 1.0%
Abdominal Pain 0.6%
Dementia Alzheimer's Type 0.6%
Depression 0.6%
Dysmenorrhoea 0.6%
Drug Administration Error 14.8%
Product Quality Issue 12.3%
Vomiting 9.9%
Weight Decreased 8.6%
Fatigue 7.4%
Intentional Drug Misuse 6.2%
Hepatitis 3.7%
Incorrect Drug Administration Duration 3.7%
Insomnia 3.7%
Multiple Drug Overdose 3.7%
Nausea 3.7%
Amnesia 2.5%
Anxiety 2.5%
Dependence 2.5%
Drug Dependence 2.5%
Hypersensitivity 2.5%
Intentional Overdose 2.5%
Liver Injury 2.5%
Pulmonary Embolism 2.5%
Systemic Lupus Erythematosus 2.5%
Concomitant
Back Pain 10.9%
Medical Diet 10.9%
Pain 10.9%
Arthritis 9.1%
Hepatitis C 9.1%
Insomnia 9.1%
Anaemia 3.6%
Ankylosing Spondylitis 3.6%
Arthropathy 3.6%
Blood Cholesterol Increased 3.6%
Cardiovascular Event Prophylaxis 3.6%
Gastrooesophageal Reflux Disease 3.6%
Hypertension 3.6%
Sjogren's Syndrome 3.6%
Contraception 1.8%
Hypersensitivity 1.8%
Osteoporosis 1.8%
Parkinson's Disease 1.8%
Premedication 1.8%
Relapsing-remitting Multiple Sclerosis 1.8%
Product Quality Issue 23.5%
Pancytopenia 11.8%
Pneumonia 11.8%
Weight Decreased 11.8%
Asthenia 5.9%
Incorrect Drug Administration Duration 5.9%
Urosepsis 5.9%
Vertigo 5.9%
Vision Blurred 5.9%
Vomiting 5.9%
Vomiting Projectile 5.9%
Interacting
Pain 54.5%
Gastrointestinal Stromal Tumour 9.1%
Headache 9.1%
Hypothyroidism 9.1%
Insomnia 9.1%
Smoking Cessation Therapy 9.1%
Drug Interaction 50.0%
Renal Failure 50.0%